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Peanut allergy is increasing Food allergy has a huge
impact on Quality of Life for the patients and their
families. Allergy is seldom reported as emergencies
from Commercial Airlines but many peanut allergic
patients’ reports symptoms during air flight by ingestion
of peanuts but mostly by inhalation.
Many peanut allergic patients avoid travelling by
airplane. The risk for reaction is controversial.
From opening peanut bags and stirring in peanut
bowl. No severe reaction was observed. 23 children were
tested. Nine patients had a mild reaction like itching of
skin, eyes or mouth or urticaria. Three patients received
treatment with antihistamine and one with oral steroid.
Only one had objectively observed symptoms.
Air travel seems to be safe with only risk of mild
symptoms in peanut allergic patient even when peanuts
are served during flight.
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